Pharmaceutical giant GlaxoSmithKline (GSK), as part of an ongoing investigation into the business’ illegal bribery practices, now faces claims that it bribed Syrian distributors to increase...
The chief executive of British drug company GlaxoSmithKline (GSK), Sir Andrew Witty, has repeated that the firm has a “zero tolerance” policy when it comes corruption...
British pharmaceuticals giant GlaxoSmithKline (GSK) has confirmed one of its former executives does appear in a sex tape – news that places further pressure on a...
British pharmaceuticals giant GlaxoSmithKline (GSK) is being investigated by the Serious Fraud Office (SFO) over the bribery allegations it faces in China, Poland and Iraq. The...
The Chinese police have accused a British GlaxoSmithKline (GSK) executive and his colleagues of having bribed hospital and government officials to prescribe the company’s drugs, running...
Swiss and British pharmaceutical giants Novartis and GlaxoSmithKline (GSK) have swapped assets and agreed on creating a joint venture that will focus on consumer healthcare. The...
British drugs firm GlaxoSmithKline (GSK) has been accused of bribing doctors to promote its products in Lodz, Poland. The allegations follow similar claims in China last...
Despite improvements, major pension schemes still need to make progress when it comes to responsible investment, a new league table compiled by the charity ShareAction shows....
A new study has accused investment funds of failing to manage climate risks properly, subsequently exposing investors to potentially huge losses in the future. The Global...
Swiss sustainability rating agency Inrate has released a new index that ranks Stoxx Europe 50 companies on their environmental and social performances. Companies from the clothing,...
Pharmaceuticals giant GlaxoSmithKline (GSK) saw its drugs sales in China fall 61% between July and September. The decline follows a bribery investigation that began in July....
Ethical campaigners have criticised the Church in Wales for investing millions into four controversial pharmaceutical companies, prompting the Church to defend its ‘solid ethical investment policy’....
Pharmaceuticals giant GlaxoSmithKline (GSK) has announced that it is replacing its head of its operations in China Mark Reilly, amid allegations of corruption in the country....
Mike Appleby, a sustainable and responsible investment (SRI) analyst at Alliance Trust, explains how the investment house squares pharmaceuticals firm GlaxoSmithKline’s status as a viable sustainable...
British drug company GlaxoSmithKline (GSK) has come under fire over allegations of bribery in China. But investors still trust the company, which remains a popular choice...